参考文献/References:
[1] 刘秀. 维生素D结合蛋白的研究现状[J]. 生命的化学(中国生物化学会通讯), 1993,14-16.
[2] Daiger SP, Schanfield MS, Cavalli-Sforza LL. Group-specific component(Gc)proteins bind vitamin D and 25-hydroxyvitamin D[J].Proc Natl Acad Sci U S A,1975,72(6):2076-2080.
[3] Speeckaert M, Huang G, Delanghe JR,et al. Biological and clinical aspects of the vitamin D binding protein(Gc-globulin)and its polymorphism[J].Clin Chim Acta,2006,372(1-2):33-42.
[4] Safadi FF,Thornton P,Magiera H,et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein[J].J Clin Invest,1999,103(2):239-251.
[5] Bouillon R, Van Assche FA, Van Baelen H,et al. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration[J].J Clin Invest,1981,67(3):589-596.
[6] White P,Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein[J].Trends Endocrinol Metab,2000,11(8):320-327.
[7] Cooke NE,Haddad JG. Vitamin D binding protein(Gc-globulin)[J].Endocr Rev,1989,10(3):294-307.
[8] Arnaud J,Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein(DBP)[J].Hum Genet,1993,92(2):183-188.
[9] Cleve H,Constans J. The mutants of the vitamin-D-binding protein: more than 120 variants of the GC/DBP system[J].Vox Sang,1988,54(4):215-225.
[10] Braun A,Brandhofer A, Cleve H. Interaction of the vitamin D-binding protein(group-specific component)and its ligand 25-hydroxy-vitamin D3: binding differences of the various genetic types disclosed by isoelectric focusing[J].Electrophoresis,1990,11(6):478-483.
[11] Kamboh MI, Ferrell RE. Ethnic variation in vitamin D-binding protein(GC): a review of isoelectric focusing studies in human populations[J].Hum Genet,1986,72(4):281-293.
[12] Powe CE, Evans MK, Wenger J,et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans[J].N Engl J Med,2013,369(21):1991-2000. DOI: 10.1056/NEJMoa1306357.
[13] Malik S, Fu L, Juras DJ,et al. Common variants of the vitamin D binding protein gene and adverse health outcomes[J].Crit Rev Clin Lab Sci,2013,50(1):1-22. DOI: 10.3109/10408363.2012.750262.
[14] Moy KA, Mondul AM, Zhang H,et al. Genome-wide association study of circulating vitamin D-binding protein[J].Am J Clin Nutr, 2014,99(6):1424-1431. DOI: 10.3945/ajcn.113.080309.
[15] Wang TJ, Zhang F, Richards JB,et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study[J].Lancet,2010,376(9736):180-188.DOI: 10.1016/S0140-6736(10)60588-0.
[16] Ahn J, Yu K, Stolzenberg-Solomon R,et al. Genome-wide association study of circulating vitamin D levels[J].Hum Mol Genet,2010,19(13):2739-2745.DOI: 10.1093/hmg/ddq155.
[17] Yousefzadeh P, Shapses SA, Wang X. Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions[J]. Int J Endocrinol,2014,2014:981581. DOI: 10.1155/2014/981581.
[18] McGrath JJ, Saha S, Burne TH,et al. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations[J].J Steroid Biochem Mol Biol,2010,121(1-2):471-477.DOI: 10.1016/j.jsbmb.2010.03.073.
[19] Santos BR, Mascarenhas LP, Boguszewski MC,et al. Variations in the vitamin D-binding protein(DBP)gene are related to lower 25-hydroxyvitamin D levels in healthy girls: a cross-sectional study[J].Horm Res Paediatr,2013,79:162-168. DOI: 10.1159/000348847.
[20] Braithwaite VS, Jones KS, Schoenmakers I,et al. Vitamin D binding protein genotype is associated with plasma 25OHD concentration in West African children[J].Bone,2015,74:166-170. DOI: 10.1016/j.bone.2014.12.068.
[21] Xu W, Sun J, Wang W,et al. Association of genetic variants of vit D binding protein(DBP/GC)and of the enzyme catalyzing its 25-hydroxylation(DCYP2R1)and serum vit D in postmenopausal women[J].Hormones(Athens),2014,13(3):345-352. DOI: 10.14310/horm.2002.1484.
[22] Mendel CM.The free hormone hypothesis: a physiologically based mathematical model[J].Endocr Rev,1989,10(3):232-274.
[23] Chun RF,Peercy BE,Orwoll ES,et al. Vitamin D and DBP: the free hormone hypothesis revisited[J].J Steroid Biochem Mol Biol,2014,144 Pt A:132-137. DOI: 10.1016/j.jsbmb.2013.09.012.
[24] Schwartz JB, Lai J, Lizaola B,et al. A comparison of measured and calculated free 25(OH)vitamin D levels in clinical populations[J].J Clin Endocrinol Metab,2014,99(5):1631-1637. DOI: 10.1210/jc.2013-3874.
[25] Yamamoto N, Kumashiro R. Conversion of vitamin D3 binding protein(group-specific component)to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells[J].J Immunol,1993,151(5):2794-2802.
[26] Schneider GB, Benis KA, Flay NW,et al. Effects of vitamin D binding protein-macrophage activating factor(DBP-MAF)infusion on bone resorption in two osteopetrotic mutations[J].Bone,1995,16(6):657-662.
[27] Lauridsen AL,Vestergaard P,Hermann AP,et al. Female premenopausal fracture risk is associated with gc phenotype[J].J Bone Miner Res,2004,19(6):875-881.
[28] Khusainova RI, Seleznyova LI, Mal'tsev AV,et al. Associations between vitamin D-binding protein(DBP)gene polymorphism(TAAA)n and development of osteoporosis in the Volga-Ural region of Russia[J].Bull Exp Biol Med,2014,157(2):253-257. DOI: 10.1007/s10517-014-2538-5.
[29] Taes YE, Goemaere S, Huang G,et al. Vitamin D binding protein, bone status and body composition in community-dwelling elderly men[J].Bone,2006,38(5):701-707.
[30] Papiha SS, Allcroft LC, Kanan RM,et al. Vitamin D binding protein gene in male osteoporosis: association of plasma DBP and bone mineral density with(TAAA)(n)-Alu polymorphism in DBP[J].Calcif Tissue Int,1999,65(4):262-266.
[31] Al-oanzi ZH, Tuck SP, Mastana SS, et al.Vitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men[J]. Osteoporos Int,2008,19: 951-960.
[32] Wang G, Li Y, Li L,et al. Association of the vitamin D binding protein polymorphisms with the risk of type 2 diabetes mellitus: a meta-analysis[J].BMJ Open,2014,4(11):e005617. DOI: 10.1136/bmjopen-2014-005617.
[33] Leong A, Rehman W, Dastani Z,et al. The causal effect of vitamin D binding protein(DBP)levels on calcemic and cardiometabolic diseases: a Mendelian randomization study[J].PLoS Med,2014,11(10):e1001751. DOI: 10.1371/journal.pmed.1001751. eCollection 2014.
[34] Michos ED, Misialek JR, Selvin E,et al. 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: The ARIC study[J].Atherosclerosis,2015,241(1):12-17.DOI: 10.1016/j.atherosclerosis.2015.04.803.
[35] Lutsey PL, Michos ED, Misialek JR,et al. Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: The(ARIC AtheroSclerosis Risk in Communities)Study[J].JACC Heart Fail, 2015,3(5):347-356. DOI: 10.1016/j.jchf.2014.11.013.
[36] Schneider AL, Lutsey PL, Selvin E,et al. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities(ARIC)study[J].Eur J Neurol,2015,22(8):1220-1227.DOI: 10.1111/ene.12731.
[37] Jorde R, Schirmer H, Wilsgaard T,et al. The DBP phenotype Gc-1f/Gc-1f is associated with reduced risk of cancer. The Troms Study[J].PLoS One,2015,10(5):e0126359. DOI: 10.1371/journal.pone.0126359. eCollection 2015.
[38] Peng Q, Yang S, Lao X,et al. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population[J].PLoS One,2014,9(12):e116026. DOI: 10.1371/journal.pone.0116026.
[39] Anic GM, Weinstein SJ, Mondul AM,et al. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer[J].PLoS One,2014,9(7):e102966.DOI:10.1371/journal.pone.0102966.
[40] Weinstein SJ, Purdue MP, Smith-Warner SA,et al. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial[J].Int J Cancer,2015,136(6):E654-E664. DOI: 10.1002/ijc.29157.
[41] Rinaldi AO, Sanseverino I, Purificato C,et al. Increased circulating levels of vitamin D binding protein in MS patients[J].Toxins(Basel),2015,7(1):129-137. DOI: 10.3390/toxins7010129.
[42] Perga S, Giuliano Albo A, Lis K,et al. Vitamin D binding protein isoforms and apolipoprotein E in cerebrospinal fluid as prognostic biomarkers of multiple sclerosis[J].PLoS One,2015,10(6):e0129291.DOI:10.1371/journal.pone.0129291.
[43] Xiao M, Wang T, Zhu T,et al. Dual role of vitamin D-binding protein 1F allele in chronic obstructive pulmonary disease susceptibility: a meta-analysis[J].Genet Mol Res,2015,14(2):3534-3540. DOI: 10.4238/2015.
相似文献/References:
[1]耿争光,王琴,邓凯,等.遵义人群载脂蛋白A5 c.553G/T基因多态性
与混合型高脂血症的相关性研究[J].国际内分泌代谢杂志,2017,37(01):6.[doi:10.3760/cma.j.issn.1673-4157.2017.01.02]
Geng Zhengguang*,Wang Qin,Deng Kai,et al.Association of apolipoprotein A5 c.553G/T gene polymorphism with combined hyperlipidemia in Zunyi population[J].International Journal of Endocrinology and Metabolism,2017,37(03):6.[doi:10.3760/cma.j.issn.1673-4157.2017.01.02]
[2]刘晓妮 王颖 李桃桃 马小敏 梁彦.血管紧张素转换酶基因rs4353多态性
与糖尿病微血管病变的相关性研究[J].国际内分泌代谢杂志,2018,38(03):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
Liu Xiaoni*,Wang Ying,Li Taotao,et al.Association between angiotensin converting enzyme gene rs4353 polymorphism and diabetic microangiopathy[J].International Journal of Endocrinology and Metabolism,2018,38(03):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
[3]孙树凯 翟玉娥 田清武 赵鹏 申井利 翟木绪.雌激素受体基因多态性与妊娠糖尿病的
相关性研究[J].国际内分泌代谢杂志,2018,38(06):361.[doi:10.3760/cma.j.issn.1673-4157.2018.06.001]
Sun Shukai*,Zhai Yu'e,Tian Qingwu,et al.Correlation between polymorphism of estrogen receptor gene and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(03):361.[doi:10.3760/cma.j.issn.1673-4157.2018.06.001]
[4]潘娟 陈霞.2型糖尿病患者FNDC5基因多态性
与颈动脉粥样硬化相关性研究[J].国际内分泌代谢杂志,2019,39(03):155.[doi:10.3760/cma.j.issn.1673-4157.2019.03.003]
Pan Juan,Chen Xia.Association between FNDC5 gene polymorphism and carotid atherosclerosis in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2019,39(03):155.[doi:10.3760/cma.j.issn.1673-4157.2019.03.003]
[5]梁绮君 余寿益 胡晨鸣 李淑华 陈诗慧 杨焱 莫巧璇.乙醛脱氢酶2基因多态性与空腹血糖受损的
相关性[J].国际内分泌代谢杂志,2019,39(04):222.[doi:10.3760/cma.j.issn.1673-4157.2019.04.002]
Liang Qijun,Yu Shouyi,Hu Chenming,et al.Association of aldehyde dehydrogenase 2 genetic polymorphism and impaired fasting glucose[J].International Journal of Endocrinology and Metabolism,2019,39(03):222.[doi:10.3760/cma.j.issn.1673-4157.2019.04.002]
[6]王英楠,成志锋.ABCG2基因多态性与痛风[J].国际内分泌代谢杂志,2020,40(05):351.[doi:10.3760/cma.j.cn121383-20200216-02026]
Wang Yingnan,Cheng Zhifeng.ABCG2 Gene polymorphism and gout Medical University, Harbin 150001, China[J].International Journal of Endocrinology and Metabolism,2020,40(03):351.[doi:10.3760/cma.j.cn121383-20200216-02026]
[7]高虹,杨静,高飞.维生素D受体基因多态性与亚洲绝经后女性骨密度相关性的荟萃分析[J].国际内分泌代谢杂志,2021,41(03):158.[doi:10.3760/cma.j.cn121383-20210225-02058]
Gao Hong,Yang Jing,Gao Fei..A meta-analysis of the association between vitamin D receptor gene polymorphism and bone mineral density in Asian postmenopausal women[J].International Journal of Endocrinology and Metabolism,2021,41(03):158.[doi:10.3760/cma.j.cn121383-20210225-02058]
[8]卓然然,付盼盼.IL-16基因多态性与GDM的关系及对妊娠结局的影响[J].国际内分泌代谢杂志,2022,42(02):118.[doi:10.3760/cma.j.cn121383-20210106-01014]
Zhuo Ranran,Fu Panpan..Association between IL-16 gene polymorphism and susceptibility to GDM and its influence on pregnancy outcome[J].International Journal of Endocrinology and Metabolism,2022,42(03):118.[doi:10.3760/cma.j.cn121383-20210106-01014]
[9]李赫岩,滕卫平,单忠艳,等.内分泌腺体中磷酸二酯酶的分布及作用研究进展[J].国际内分泌代谢杂志,2022,42(02):129.[doi:10.3760/cma.j.cn121383-20201201-12003]
Li Heyan,Teng Weiping,Shan Zhongyan,et al.Distribution and function of phosphodiesterases in endocrine glands[J].International Journal of Endocrinology and Metabolism,2022,42(03):129.[doi:10.3760/cma.j.cn121383-20201201-12003]